Insiders G1 Therapeutics, Inc.

Equities

GTHX

US3621LQ1099

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-05 pm EDT			5-day change	1st Jan Change
3.21 ^USD	+0.47%		-3.89%	+5.25%

May. 28	G1 Therapeutics, Inc. Announces the Presentation of Mature Phase 2 Clinical Trial Results	CI
May. 23	G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology Meeting	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

G1 Therapeutics, Inc. Announces Resignation of Mark A. Velleca from the Board of Directors, Effective as of September 30, 2023	23-09-21	CI
Insider Sell: G1 Therapeutics	23-08-10	MT
G1 Therapeutics Announces Appointment of Monica Thomas as Chief Compliance Officer	23-05-23	CI
G1 Therapeutics Appoints Monica Thomas as General Counsel	23-05-22	MT
Insider Sell: G1 Therapeutics	22-10-20	MT
Insider Sell: G1 Therapeutics	22-09-16	MT
Day One Biopharmaceuticals Says Garry Nicholson Named Chairman	22-09-12	MT
Insider Sell: G1 Therapeutics	22-08-18	MT
G1 Therapeutics Announces Addition of Norman E. Sharpless to Board of Directors	22-07-25	CI
G1 Therapeutics, Inc. Announces Resignation of Willie A. Deese from the Board	22-06-28	CI
G1 Therapeutics Inc. Appoints Jacks Lee to Board of Directors	22-06-28	CI
G1 THERAPEUTICS NAMED 2022 LIFE SCIENCES PUBLIC COMPANY OF THE YEAR BY TRIANGLE BUSINESS JOURNAL	22-05-23	AQ
G1 Therapeutics Named 2022 Life Sciences Public Company of the Year by Triangle Business Journal	22-05-20	AQ
Insider Sell: G1 Therapeutics	22-01-06	MT
G1 Therapeutics, Inc. Announces Resignation of Seth A. Rudnick from Board of Directors	21-10-15	CI
G1 Therapeutics, Inc. Announces Executive Changes	21-08-02	CI
G1 Therapeutics Announces Addition of Alicia Secor to Board of Directors	21-06-18	CI
G1 Therapeutics, Inc. Announces Resignation of Fredric N. Eshelman, Pharm.D. as Board of Directors	21-04-23	CI
Insider Trends: Insider Sale at G1 Therapeutics Slowing 90-Days of Buying	20-12-23	MT
Insider Trends: G1 Therapeutics Sees 90 Days of Insider Buying Trend Reducing with Share Sale	20-12-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders G1 Therapeutics, Inc.

Equities

GTHX

US3621LQ1099

Insiders

Filters